Filter
143
Text search:
generics
Featured
Recommendations
14
New Publications
39
Language
Document type
No document type
65
Studies & Reports
43
Guidelines
22
Strategic & Response Plan
6
Manuals
4
Situation Updates
2
Infographics
1
Countries / Regions
Global
10
India
5
Kenya
5
Ghana
4
South Africa
4
Ukraine
4
Philippines
3
Tanzania
3
Namibia
3
Sierra Leone
2
Nigeria
2
Senegal
2
Ethiopia
2
Uganda
2
Haiti
2
Rwanda
2
Indonesia
2
Malawi
2
Lesotho
2
Latin America and the Carribbean
2
Western and Central Europe
2
Burkina Faso
1
Zimbabwe
1
Germany
1
Syria
1
Eswatini/ Swaziland
1
Brazil
1
Botswana
1
Myanmar / Burma
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Albania
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
20
Public Health
10
Pharmacy & Technologies
9
Women & Child Health
2
Toolboxes
Pharmacy
22
HIV
21
AMR
19
NCDs
12
TB
5
COVID-19
5
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Conflict
2
Refugee
2
Planetary Health
2
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modul
...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
Economic Issues, Policies and Option for Action
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidly implemented in countries, in the short to medium
...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy
...
Worldwide, there are about 17 million deaths due to cardiovascular disease (CVD) each year and at least two or three times as many non-fatal events. Raised cholesterol greatly increases the risks of stroke and heart disease, causing a large
health burden across the world. The World Health Organizat
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
